Status:
RECRUITING
Multi-Modality Imaging Standard Cohort Of Cerebrovascular Disease
Lead Sponsor:
Beijing Tiantan Hospital
Conditions:
Cerebrovascular Disease
Eligibility:
All Genders
18-80 years
Brief Summary
The aim of this study is to establish a multi-center and multi-modality imaging standard cohort of cerebrovascular disease, analyze the potential mechanisms affecting the prognosis of cerebrovascular ...
Detailed Description
Cerebrovascular diseases are major diseases that pose a serious threat to human health and life, and have become the leading cause of death from disease among Chinese residents. Despite the best medic...
Eligibility Criteria
Inclusion
- Age between 18 and 80 years old;
- Onset of symptoms within 7 days;
- Clinical diagnosis of cerebrovascular disease (ischemic stroke or hemorrhagic stroke) confirmed by head imaging (CT or MRI);
- Signed informed consent form.
Exclusion
- Diagnosed with non-cerebrovascular diseases (such as central nervous system infections, epilepsy, and metabolic encephalopathy);
- Patients with contraindications to multimodal CT or MRI, functional near-infrared imaging, or those who cannot cooperate to complete the relevant examinations;
- Patients with a life expectancy of less than 3 months or those who cannot complete the study follow-up due to other reasons.
Key Trial Info
Start Date :
January 1 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 30 2027
Estimated Enrollment :
800 Patients enrolled
Trial Details
Trial ID
NCT06925178
Start Date
January 1 2025
End Date
September 30 2027
Last Update
April 13 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Beijing Tiantan Hospital
Beijing, Beijing Municipality, China, 100070